Skip to content

Cross-linked and Non-cross-linked Hyaluronic Acid in Subdeltoid Bursitis

Comparing the Efficacy of Cross-Linked and Non-Cross-Linked Hyaluronic Acid in Treating Subdeltoid Bursitis: A Double-Blind, Randomized Clinical Trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06508125
Enrollment
52
Registered
2024-07-18
Start date
2024-07-25
Completion date
2024-12-31
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyaluronic Acid, Subdeltoid Bursitis

Keywords

Subdeltoid Bursitis, Hyaluronic acid, cross linked

Brief summary

This study aims to compare the efficacy of different structures of hyaluronic acid, namely cross-linked and non-cross-linked hyaluronic acid, in treating subdeltoid bursitis.

Detailed description

A double-blind, randomized clinical trial will be conducted to collect 52 patients with subdeltoid bursitis. The patients will be injected with cross-linked or non-cross-linked hyaluronic acid under ultrasound guidance. Before treatment, one week after treatment (i.e., one week after injection), one month after treatment, and three months after treatment to detect shoulder pain (visual analog scale; pressure ergometer to measure pain pressure threshold), function (including Disabilities of the Arm, Shoulder, and Hand: DASH and Shoulder Pain and Disability Index: SPADI), quality of life (Brief version of the World Health Organization Quality of Life Scale: WHOQOL-BREF) will be arranged.

Interventions

cross-linked hyaluronic acid injection with physical therapy

DRUGnon-cross-linked hyaluronic acid

non-cross-linked hyaluronic acid injection with physical therapy

Sponsors

Taipei Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of subdeltoid bursitis * age 20 or older 20 * at least one positive in the painful arc, neer test, or Hawkins test * can attend three months of intervention and follow-up

Exclusion criteria

* history of malignancy * previous shoulder operation or injury * previous shoulder injections in the past three months

Design outcomes

Primary

MeasureTime frameDescription
Shoulder pain and disability indexscore change from baseline to 1 week, 1 month and 3 months after treatmentmeasure shoulder pain and disability, ranges from 0-100, higher scores indicate more pain or disability

Secondary

MeasureTime frameDescription
Disabilities of the arm, shoulder, and handscore change from baseline to 1 week, 1 month and 3 months after treatmentmeasure sports/music and work related to shoulder pain, ranges from 0-100, higher scores indicate more pain or disability
Visual analog scalescore change from baseline to 1 week, 1 month and 3 months after treatmentmeasure shoulder pain, ranges from 0-10, higher score indicate more pain
range of motionscore change from baseline to 1 week, 1 month and 3 months after treatmentmeasure shoulder range of motion, higher score indicate higher range of motion
Brief version of the World Health Organization Quality of Life Scalescore change from baseline to 1 week, 1 month and 3 months after treatmentmeasure quality of life, ranges from 0-100, higher scores indicate better quality of life

Countries

Taiwan

Contacts

Primary ContactRu-Lan Hsieh, MD
M001052@ms.skh.org.tw882-2-28332211

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026